Scientist Solutions: International Life Science Community By Scientists For Scientists

Thanks to our sponsors who make this site possible

    

Scientist-Solutions

 



Google+

At Scientist Solutions we cherish our role as a trusted source of information for scientists.  We hope that our newly designed site will make it easier than ever for you to access everything we have to offer.   Things may have moved around a little, but rest assured that all the features you enjoyed on our old site (the forums, the protocols, the events, my bench space, blogs)  are still here.  

Our Discussion Forums

Scientist Solutions began as a discussion board for life scientists and that is still one of our core offerings.   If you are looking for the discussion forums, please click "The Forums"  from the navigation bar above or click here.

Protocols and SciEvents

Always on the look out for new ways to help scientists to help each other,  Scientist Solutions introduced a new protocols section and an events section to our site in the past year.   Both have been very popular.   If you haven't yet discovered these listings, we invite you to do so now. 

Our Protocol Finder provides an easily searchable database of protocols that you can use both to find a protocol you need or to share the protocols that you rely on.  Just click "Protocol Finder" from the navigation bar above, or click here.

Our SciEvents section is setting out to be the most comprehensive listing of conferences, seminars, classes and webinars for life scientists on the web.   Search events listings by date, topic or type of event.    You are most welcome to add your own events to our listing too.   Just click SciEvents from the navigation bar above, or click here.

My Bench SpaceMembership Management

Are you looking for how to log in or wondering what happened to your bench space?     On our new site, we have made it much easier for you to manage your account and profile.   After logging in (note that the log in area has moved down the page),  you will see your new member status panel on the right hand side of the home page and every page.    Look here for an overview of your member information and find easy access to your newly remodeled My Bench Space, where you'll be able to edit your account information and preferences and manage your public profile.   Just click "Go to My Bench Space" from your member status panel or click here.

Blogging

Notice that featured blogs are now presented on the home page just below this article.   To read all blogs, just click the "view more" link below the featured blogs.   To create your own blog, go to your My Bench Space pages and click on the "blogs" tab.  To get to My Bench Space, log in then click the "Go to My Bench Space" link in your member status panel (see above) or just click here

Give us your feedback

We understand that it takes a little adjustment time to get used to a new design.  We apologize for any temporary confusion, but hope that once you've familiarized yourself with the new design and features you will be very pleased.   Either way, we would love to hear what you think.  Please share your opinion by clicking the 'contact us'  link at the top right of any page and send us a note or click here.




Latest Member Blogs

Member
Total Posts: 1
6/14/2017
09:29PM
Member
Total Posts: 1
6/14/2017
02:18PM
Member
Total Posts: 1
6/13/2017
09:49AM




Science News Feeds

Click a source to select it and see feeds below

BioScience News
Pharmaceutical News
Biotechnology News
Today's Science News
This Week in Science
Science (Editorial)
Science Now
Nextwave
New York Times
BBC
Bioscreening
Journals
Journal of Biology
Nature
European Journal of Cell Biology
Virology Journal
Science
PNAS
Magazines
New Scientist
The Scientist
Pharmaceutical Business Review
Life Sciences World
Science News

Biotechnology - Google News
Google News
This RSS feed URL is deprecated
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news
Jefferies Group Weighs in on Arrowhead Pharmaceuticals' Q2 2018 Earnings (ARWR) - StockNewsTimes

StockNewsTimes

Jefferies Group Weighs in on Arrowhead Pharmaceuticals' Q2 2018 Earnings (ARWR)
StockNewsTimes
Arrowhead Pharmaceuticals (NASDAQ:ARWR) – Equities research analysts at Jefferies Group issued their Q2 2018 earnings estimates for Arrowhead Pharmaceuticals in a report released on Tuesday, March 27th, according to Zacks Investment Research. Jefferies ...

and more »
Allianz Asset Management GmbH Acquires 1049 Shares of Puma Biotechnology Inc (PBYI) - StockNewsTimes

Allianz Asset Management GmbH Acquires 1049 Shares of Puma Biotechnology Inc (PBYI)
StockNewsTimes
Allianz Asset Management GmbH lifted its stake in shares of Puma Biotechnology Inc (NASDAQ:PBYI) by 31.4% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 4,392 shares of the ...

and more »
iShares NASDAQ Biotechnology Index (IBB) Holding Grow by Capital Fund Management SA - BangaloreWeekly

iShares NASDAQ Biotechnology Index (IBB) Holding Grow by Capital Fund Management SA
BangaloreWeekly
Several other hedge funds also recently added to or reduced their stakes in IBB. Mycio Wealth Partners LLC increased its stake in shares of iShares NASDAQ Biotechnology Index by 6.2% in the first quarter. Mycio Wealth Partners LLC now owns 2,938 shares ...

and more »
Glenmede Trust Co. NA Has $863000 Stake in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) - The Lincolnian Online

The Lincolnian Online

Glenmede Trust Co. NA Has $863000 Stake in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)
The Lincolnian Online
Glenmede Trust Co. NA lifted its position in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 224.8% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 8,098 shares of the financial ...

and more »
Puma Biotechnology, Inc. (NYSE:PBYI): Trader Update on the Shares - Carthage Standard

Puma Biotechnology, Inc. (NYSE:PBYI): Trader Update on the Shares
Carthage Standard
According to the latest stock data, investors are looking at Puma Biotechnology, Inc. (NYSE:PBYI)'s short data and trying to figure out market sentiment on which way the market thinks the stock is moving. The firm has 10.00% of total shares float short ...

and more »
Puma Biotechnology Inc (NASDAQ:PBYI) Shares Sold by Alliancebernstein LP - registrarjournal.com

Puma Biotechnology Inc (NASDAQ:PBYI) Shares Sold by Alliancebernstein LP
registrarjournal.com
Alliancebernstein L.P. trimmed its position in shares of Puma Biotechnology Inc (NASDAQ:PBYI) by 7.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 60 ...

and more »
Somewhat Favorable News Coverage Somewhat Unlikely to Affect ProShares UltraShort Nasdaq Biotechnology (BIS ... - The Lincolnian Online

The Lincolnian Online

Somewhat Favorable News Coverage Somewhat Unlikely to Affect ProShares UltraShort Nasdaq Biotechnology (BIS ...
The Lincolnian Online
Headlines about ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) have been trending somewhat positive on Friday, Accern Sentiment Analysis reports. Accern scores the sentiment of press coverage by reviewing more than 20 million news and blog ...

and more »
Global Liraglutide Market 2018 Players| Teva, HEC Pharm, Kingpep Biotechnology and Bharat Pharmaceuticals - The Financial Analyst

Global Liraglutide Market 2018 Players| Teva, HEC Pharm, Kingpep Biotechnology and Bharat Pharmaceuticals
The Financial Analyst
Global Liraglutide Market Report illustrates the present development status of Liraglutide along with the growth of Liraglutide expected during the forecast period during 2017-2022. Liraglutide Market analyses the industry based on different factors ...

Are The Quant Signals Kicking up a Fuss for Puma Biotechnology, Inc. (NasdaqGS:PBYI)? - Yankee Analysts

Are The Quant Signals Kicking up a Fuss for Puma Biotechnology, Inc. (NasdaqGS:PBYI)?
Yankee Analysts
In trying to determine the current valuation of Puma Biotechnology, Inc. (NasdaqGS:PBYI) shares, we note that the Book to Market ratio of the shares stands at 0.022664. It's commonly accepted that a Book to Market ratio greater than one indicates that ...

and more »
Are The Quant Signals Kicking up a Fuss for Puma Biotechnology, Inc. (NasdaqGS:PBYI)? - Yankee Analysts

Are The Quant Signals Kicking up a Fuss for Puma Biotechnology, Inc. (NasdaqGS:PBYI)?
Yankee Analysts
In trying to determine the current valuation of Puma Biotechnology, Inc. (NasdaqGS:PBYI) shares, we note that the Book to Market ratio of the shares stands at 0.022664. It's commonly accepted that a Book to Market ratio greater than one indicates that ...